Skip to content
10-K

Annual Report

Jazz Pharmaceuticals plc JAZZ

0001232524-26-000013

← back to feed
Filed
Feb 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 17, 2026 61.56M sh
Shares Diluted FY 2025 · Dec 31, 2025 60.98M sh
Shares Diluted FY 2025 · Dec 31, 2024 66.01M sh
Shares Diluted FY 2025 · Dec 31, 2023 72.07M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $125.02M
Stock Repurchased FY 2025 · Dec 31, 2024 $311.43M
Stock Repurchased FY 2025 · Dec 31, 2023 $269.76M
Capex FY 2025 · Dec 31, 2025 $58.75M
Capex FY 2025 · Dec 31, 2024 $38.07M
Capex FY 2025 · Dec 31, 2023 $23.96M
Operating Cash Flow FY 2025 · Dec 31, 2025 $1.36B
Operating Cash Flow FY 2025 · Dec 31, 2024 $1.4B
Operating Cash Flow FY 2025 · Dec 31, 2023 $1.09B
Long Term Debt FY 2025 · Dec 31, 2025 $4.33B
Long Term Debt FY 2025 · Dec 31, 2024 $6.08B
Short Term Debt FY 2025 · Dec 31, 2025 $1.03B
Short Term Debt FY 2025 · Dec 31, 2024 $31M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.39B
Cash And Equivalents FY 2025 · Dec 31, 2024 $2.41B
Stockholders Equity FY 2025 · Dec 31, 2025 $4.32B
Stockholders Equity FY 2025 · Dec 31, 2024 $4.09B
Stockholders Equity FY 2025 · Dec 31, 2023 $3.74B
Stockholders Equity FY 2025 · Dec 31, 2022 $3.09B
Current Liabilities FY 2025 · Dec 31, 2025 $2.24B
Current Liabilities FY 2025 · Dec 31, 2024 $1.04B
Current Assets FY 2025 · Dec 31, 2025 $4.17B
Current Assets FY 2025 · Dec 31, 2024 $4.63B
Total Assets FY 2025 · Dec 31, 2025 $11.66B
Total Assets FY 2025 · Dec 31, 2024 $12.01B
Eps Diluted FY 2025 · Dec 31, 2025 −$5.84
Eps Diluted FY 2025 · Dec 31, 2024 $8.65
Eps Diluted FY 2025 · Dec 31, 2023 $6.10
Eps Basic FY 2025 · Dec 31, 2025 −$5.84
Eps Basic FY 2025 · Dec 31, 2024 $9.06
Eps Basic FY 2025 · Dec 31, 2023 $6.55
Sga Expense FY 2025 · Dec 31, 2025 $1.81B
Sga Expense FY 2025 · Dec 31, 2024 $1.39B
Sga Expense FY 2025 · Dec 31, 2023 $1.34B
Net Income FY 2025 · Dec 31, 2025 −$356.15M
Net Income FY 2025 · Dec 31, 2024 $560.12M
Net Income FY 2025 · Dec 31, 2023 $414.83M
Operating Income FY 2025 · Dec 31, 2025 −$430.24M
Operating Income FY 2025 · Dec 31, 2024 $716.63M
Operating Income FY 2025 · Dec 31, 2023 $578.58M
Revenue FY 2025 · Dec 31, 2025 $4.27B
Revenue FY 2025 · Dec 31, 2024 $4.07B
Revenue FY 2025 · Dec 31, 2023 $3.83B